Objective:: To compare die effect of two different limes of ousel of lutcal phase support on ongoing pregnancy rale in infertile patients undergoing treatment with GnRH down-regulated IVF and embryo transfer (IVF/ET). Design: prospective randomized trial. Setting : Assisted reproductive tecbnology program at the shatby university hospital for women , and Madina infertility Private center in Alexandria. Patients : one hundred and forty patients undergoing IVF-ICSI program. Intervention: All palicnls planned to undergo Iheir first IVF treatment cycle were randomly allocated lo receive parentral progesterone as luteal support at two different lime points, that is, the clay before embryo transfer (ET) and til the day of ET. The primary endpoint of ibis study was ongoing pregnancy rale.
INTRODUCTION
The use of GnRH agonists for preventing premature LH surges in controlled ovarian hypcrstirnulation in IVF/embryo transfer (IVF/ET) has greatly improved the planning of oocyte retrieval (OR). Pituitary function does not resume completely until 2-3weeks after the end of GnRH-agonist characterized by a decline in serum eslradiol (E,) and progesterone 8 days after HCG administration for oocyte maturation* 1 *. This decline in steroids was thought lo have a negative effect on pregnancy rale and exogenous supplementation of progesterone or HCG, i.e. luteal phase support, proved indeed lo he mandatory (2, 3 after OR compared to 3 days after OR (5) . In the third study, no difference was found when luteal phase support was started at OR compared to starting at ET (6) .
The chosen time points of the start of progesterone support assessed in these randomized studies, however, did not cover the complete implantation window.
The aim of this study, therefore, was to assess the impact of the onset of progesterone support on ongoing pregnancy rate. 
MATERIALS & METHODS
The study included 140 women undergoing IVF-ICSI program for both male and female infertility.
These women were counseled about the experimental nature of the protocol, and a signed consent was obtained from every patient and her partner to be included in the study. Patients were randomly divided into two equal groups .
After informed consent, patients were assigned to two different luteal phase support groups and 
RESULTS
The study included 140 women undergoing IVF-ICSI program for male, and/or female infertility. Mean serum E 2 and progesterone levels did nol differ between the two groups . Lastly, there were no significant differences between the two groups in biochemical, clinical and ongoing pregnancies or live birth rates. 3.06) (95% CI 1.59-5.86) (3) with similar ongoing pregnancy rates.
In conclusion we could not identify, within the chosen time points and wilhin the sample size, a specific implantation window period in which an optimal endometrial receptivity yields the highest pregnancy rate. Further conlrolled randomized clinical trials are needed to confirm these preliminary data.
